Home
Celon Pharma

Celon Pharma Market Share Analysis for May 2026

Celon Pharma S.A. jest zintegrowaną firmą farmaceutyczną prowadzącą zaawansowane badania naukowe i wytwarzającą nowoczesne leki. Firma prowadzi również skuteczny marketing własnych produktów. Nasze leki pomagają tysiącom pacjentów zachować lepsze i dłuższe życie.

Health > Biotechnology and Pharmaceuticals

Domaincelonpharma.com

Year Founded2002

Employees201 - 500

Annual Revenue$15M - $25M

Celon Pharma

Celon Pharma (including company regionals)

celonpharma.com

See more website traffic and engagement information

Celon Pharma Revenue up to May 2026 is 15M - 25M

revenue generated by Celon Pharma top domains

Celon Pharma top domains revenue over 3 years

Revenue for Celon Pharma top domains

celonpharma.com15M - 25M

See more with Sales Intelligence

Total visits to Celon Pharma's top domains

Understand Celon Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

celonpharma.com10.1K

See more with Sales Intelligence

Avg. visit duration in Celon Pharma's top domains

Analyze Celon Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

celonpharma.com00:00:32

See more with Sales Intelligence

Avg. pageviews on Celon Pharma's top domains

See how Celon Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

celonpharma.com1.46

See more with Sales Intelligence

Celon Pharma top competitors by domain

Top similar sites in May 2026, ranked by their affinity

astrazeneca.comCompany NameAstraZenecaEmployees> 10001HQUnited Kingdom, CambridgeAnnual revenue> $1BTotal visits1.4MHealth > Biotechnology and Pharmaceuticals

Top technologies used by Celon Pharma

These are the website technologies, by industry, used by Celon Pharma top domains

Payment & Currencies (22)

PayPal

Social (8)

Google+ Platform

Widget (4)

Twemoji

Content Management System (2)

WordPress

More Technologies

5

See all

News & Signals from Celon Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCelon Pharma Ltd partnered with Pharmalink Drug Store on Jun 8th '26.The Management Board of Celon Pharma S.A. (the "Company") hereby announces that on 8 June 2026 it entered into a License and Supply Agreement with Pharmalink Drug Store L.L.C. ("Pharmalink") for the commercialization of Celon Pharma's Reduzek (semaglutide products) in multi-dose pens for subcutaneous injection.

NewsCelon Pharma Ltd received financing of $26.6M in loan on Mar 9th '26.Further to Current Report No. 13/2025 dated August 4, 2025, regarding the agreement with the European Bank for Reconstruction and Development ("EBRD") on the principal terms and conditions of financing to be granted to Celon Pharma Slovakia s.r.o. (a wholly owned subsidiary of Celon Pharma S.A., hereinafter the "Borrower"), the Management Board of Celon Pharma S.A. (the "Issuer") hereby announces that on March 9, 2026, the parties entered into a financing agreement (the "Agreement"), pursuant to which the EBRD agreed to provide the Borrower with financing in the form of a loan of up to EUR 23 million for the implementation of a project involving the adaptation, equipping and commissioning of a manufacturing facility located in the Žilina region of Slovakia for the production of the active pharmaceutical ingredient semaglutide, a GLP-1 analogue, intended for the treatment of type 2 diabetes (to be marketed under the trade name Reduzek).

NewsBartosz Szałek left Celon Pharma Ltd as Member of the Management Board and on Feb 27th '26.The Management Board of Celon Pharma S.A. (the "Company") hereby announces that on February 27, 2026, Mr. Bartosz Szałek submitted his resignation from the positions of Member of the Management Board and Chief Financial Officer of the Company, effective as of the same date, for personal reasons.